Class IITerminatedD-0600-2021
Drug recall · June 9, 2021
Micardis Tablets recall
Why: Subpotent Drug
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Micardis Tablets, (telmisartan Tablets) 80 mg, 30 ct. per folding cartons, Rx only, NDC 0597-0041-37), Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877
- Lots / codes
Lot #860412; SEPT 2022
- Quantity
- 15,198 bottles (30 tablets per bottle)
- Company
- Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT
- Distribution
- AR, CO, CT, LA, NC, ND, NH, NJ, OH, PA and PR
- Initiated
- May 4, 2021 · Voluntary: Firm initiated
- Classified
- May 28, 2021
- Reported
- June 9, 2021
- Ended
- October 14, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Telmisartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.